[Federal Register Volume 77, Number 36 (Thursday, February 23, 2012)]
[Notices]
[Page 10758]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-4212]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; Comment Request; Application for
Collaboration With the NIH Center for Translational Therapeutics (NCTT)
SUMMARY: Under the provisions of Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National Center for Advancing Translational
Sciences (NCATS), the National Institutes of Health (NIH) has submitted
to the Office of Management and Budget (OMB) a request for review and
approval of the information collection listed below. This proposed
information collection was previously published in the Federal Register
on November 11, 2011, page 69743-69744 and allowed 60-days for public
comment. No public comments were received. The purpose of this notice
is to allow an additional 30 days for public comment. The National
Institutes of Health may not conduct or sponsor, and the respondent is
not required to respond to, an information collection that has been
extended, revised, or implemented on or after October 1, 1995, unless
it displays a currently valid OMB control number.
Proposed Collection: Title: Application for collaboration with the
NIH Center for Translational Therapeutics (NCTT) . Type of Information
Collection Request: New. Need and Use of Information Collection:
Programs at the NCTT provide opportunities to partner with and gain
access to both common and specifically rare and neglected disease
through a variety of programs delivering assay development, screening,
hit to lead chemistry, lead optimization, chemical biology studies,
drug development capabilities, expertise, and clinical/regulatory
resources in a collaborative environment with the goal of moving
promising therapeutics into human clinical trials. NCTT uses an
application and evaluation process to select collaborators. Selected
investigators provide the drug project starting points and ongoing
biological/disease expertise throughout the project. Frequency of
Response: Once per year. Affected Public: Research scientists. Type of
Respondents: not-for-profits, for-profit, governmental. The annual
reporting burden is as follows: Estimated Number of Respondents: 170.
Estimated Number of Responses per Respondent: 1. Average Burden Hours
Per Response: 1. Estimated Total Annual Burden Hours Requested: 510.
Estimates of Hour Burden
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Forms Number of responses per hours per Total annual
respondents respondent response burden hours
----------------------------------------------------------------------------------------------------------------
Online Collaborator Solicitation........ 170 1 1 170
NCTT Project Information Template....... 170 1 1 170
Solicitation Instructions (TRND)........ 100 1 1 100
Solicitation Instructions (BrIDGs)...... 70 1 1 70
�����������������������������������������
Total............................... ................ ................ ................ 510
----------------------------------------------------------------------------------------------------------------
The annualized cost to respondents is estimated at: $21,261.
Capital Costs are $0. Operating Cost is roughly $14,333 for the
database to accept and coordinate responses.
Request for Comments: Written comments and/or suggestions from the
public and affected agencies are invited on one or more of the
following points: (1) Whether the proposed collection of information is
necessary for the proper performance of the function of the agency,
including whether the information will have practical utility; (2) The
accuracy of the agency's estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (3) Ways to enhance the quality, utility, and
clarity of the information to be collected; and (4) Ways to minimize
the burden of the collection of information on those who are to
respond, including the use of appropriate automated, electronic,
mechanical, or other technological collection techniques or other forms
of information technology.
Direct Comments to OMB: Written comments and/or suggestions
regarding the item(s) contained in this notice, especially regarding
the estimated public burden and associated response time, should be
directed to the: Office of Management and Budget, Office of Regulatory
Affairs, [email protected] or by fax to 202-395-6974,
Attention: Desk Officer for NIH. To request more information on the
proposed project or to obtain a copy of the data collection plans and
instruments, contact: Dr. Helen Gift, Chief, Disease Prevention and
Health Promotion Branch, DEODP, NIDCR, NIH, Natcher Building, Room 3AN-
44D, 9000 Rockville Pike, Bethesda, MD 20892, or call non-toll-free
number 301-594-5579 or Email your request, including your address to:
[email protected].
Comments Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 30-days
of the date of this publication.
Dated: February 15, 2012.
John McKew,
Chief, Preclinical Development Branch, NIH Center for Translational
Therapeutics, National Center for Advancing Translational Sciences,
National Institutes of Health.
[FR Doc. 2012-4212 Filed 2-22-12; 8:45 am]
BILLING CODE 4140-01-P